Roman Shabrov Participated in the Russian Pharmaceutical Forum “Ensuring Drug Security”

 Roman Shabrov, attorney and partner at BRACE Law Firm, participated in the Russian Pharmaceutical Forum “Ensuring Drug Security” held on June 3, 2026, at the ExpoForum venue in St. Petersburg. The forum's business program addressed critical issues concerning pharmaceutical sovereignty, the regulation of medicines circulation, public procurement, and the protection of intellectual property rights within the pharmaceutical industry.

The forum focused on ensuring national drug security, including supplying citizens with safe, high-quality, and effective pharmaceutical products, achieving pharmaceutical sovereignty, and driving the scientific and technological development of the sector.

The business program featured sessions across a broad spectrum of topics, including:

• Pharmaceutical sovereignty and reducing import reliance on active pharmaceutical ingredients (APIs);
• Strategically important medicinal products (SIMPs), deepening production localization, and the "second-is-odd-man-out" mechanism in public procurement;
• Intellectual property in the pharmaceutical sector and the application of compulsory licensing mechanisms;
• Accelerating market access for innovations and transitioning to value-based assessments of medicinal products;
• Drug provision for rare (orphan) diseases;
• Personalized and innovative oncology, including CAR-T and TCR-T cellular technologies;
• The application and legal regulation of artificial intelligence (AI) in the life sciences sector;
• Safety regulations within aesthetic medicine.

These areas intersect industry regulation, public procurement, antitrust law, and patent law, driving significant practical interest for legal professionals counselling pharmaceutical companies. Engaging in such specialized industry platforms enables legal counsel to track evolving regulations in medicine circulation and seamlessly integrate these shifts into business support strategies.

BRACE Law Firm provides high-end legal services to domestic and international businesses across Russia and the EAEU (Eurasian Economic Union) on matters of domestic and international law. Our core Life Sciences practice focuses on advising on dispute resolution, commercial operations, navigating foreign economic activity (FEA) and customs law, structuring public and corporate procurement, and handling antitrust compliance and disputes.